Celosia Therapeutics raised $16.75M in Series A funding led by Uniseed to develop its ALS gene therapy CTx1000.
Amount Raised
$16.8 Million
Round Type
Series A
SydneyBiotechnologyHealth CareTherapeuticsInvestors
Description
Celosia Therapeutics has secured $16.75 million in a Series A funding round to advance its CTx1000 gene therapy program for ALS. The round was led by Uniseed, with significant contributions from hedge fund manager Iomar Barrett and UniSuper.
Quick answer
Celosia Therapeutics raised $16.8 Million in a Series A round, dated November 28, 2024. Investors: Iomar Barrett, UniSuper and Uniseed. Celosia Therapeutics is based in Sydney, New South Wales, Australia.
- How much did Celosia Therapeutics raise?
- Celosia Therapeutics raised $16.8 Million in a Series A round on November 28, 2024.
- Who invested in Celosia Therapeutics?
- Iomar Barrett, UniSuper and Uniseed are named as investors in this round.
- What does Celosia Therapeutics do?
- Celosia Therapeutics is an Australian biotechnology company focused on developing advanced gene therapies for neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS).
- Where is Celosia Therapeutics based and how big is it?
- Celosia Therapeutics is based in Sydney, New South Wales, Australia.
- Who are the decision-makers at Celosia Therapeutics?
- Fundz holds 1 contact at Celosia Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Celosia Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Windward Bio raised $200M (Series A) on January 10, 2025.
- Ouro Medicine raised $120M (Series A) on January 10, 2025.
- Numab Therapeutics raised $55M (Series C) on January 10, 2025.
- Verdiva Bio raised $411M (Series A) on January 9, 2025.
- RyboDyn raised $4M (Pre-Seed) on January 9, 2025.
- Geneoscopy raised $105M (Series C) on January 8, 2025.
Who to call at Celosia Therapeutics, and when
A new round usually means Celosia Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Celosia Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Celosia Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Celosia Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Celosia Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCelosia Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.